Third universal definition of myocardial infarction.

Biological Markers/blood; Cardiovascular Surgical Procedures/adverse effects; Clinical Trials as Topic; Diagnostic Imaging; Electrocardiography; Heart Failure/complications; Humans; Myocardial Infarction/blood/classification/diagnosis/etiology; Public Policy; Quality Assurance, Health Care; Recurrence; Terminology as Topic

Disciplines :

Cardiovascular & respiratory systems

Author, co-author :

Thygesen, Kristian

Alpert, Joseph S.

Jaffe, Allan S.

Simoons, Maarten L.

Chaitman, Bernard R.

White, Harvey D.

Katus, Hugo A.

Apple, Fred S.

Lindahl, Bertil

Morrow, David A.

More authors (91 more)

Language :

English

Title :

Third universal definition of myocardial infarction.

Publication date :

2012

Journal title :

Journal of the American College of Cardiology

ISSN :

0735-1097

eISSN :

1558-3597

Publisher :

Elsevier, Netherlands

Volume :

Issue :

Pages :

1581-98

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 21 November 2014

Statistics

Number of views

593 (1 by ULiège)

Number of downloads

2 (1 by ULiège)

More statistics

Scopus citations^®

2577

Scopus citations^®
without self-citations

2530

OpenCitations

2106

OpenAlex citations

2492

Bibliography

The Joint European Society of Cardiology/American College of Cardiology Committee Myocardial infarction redefined - A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction Eur Heart J 21 2000 1502 1513 J Am Coll Cardiol 2000;36:959-69
K. Thygesen, J.S. Alpert, H.D. White Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction Universal definition of myocardial infarction Eur Heart J 28 2007 2525 2538 Circulation 2007;116:2634-53; J Am Coll Cardiol 2007;50:2173-95
S. Mendis, K. Thygesen, K. Kuulasmaa Writing group on behalf of the participating experts of the WHO consultation for revision of WHO definition of myocardial infarction World Health Organization definition of myocardial infarction: 2008-09 revision Int J Epidemiol 40 2011 139 146
R.B. Jennings, C.E. Ganote Structural changes in myocardium during acute ischemia Circ Res 35 Suppl 3 1974 156 172
A.S. Jaffe, L. Babuin, F.S. Apple Biomarkers in acute cardiac disease J Am Coll Cardiol 48 2006 1 11
H.D. White Pathobiology of troponin elevations J Am Coll Cardiol 57 2011 2406 2408
A.S. Jaffe Chasing troponin: how low can you go if you can see the rise? J Am Coll Cardiol 48 2006 1763 1764
F.S. Apple, R.L. Jesse, L.K. Newby, A.H.B. Wu, R.H. Christenson National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers Cardiac Damage Laboratory Medicine Practice Guidelines: Analytical issues for biochemical markers of acute coronary syndromes Circulation 115 2007 e352 e355
D.A. Morrow, C.P. Cannon, R.L. Jesse National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical characteristics and utilization of biochemical markers of acute coronary syndromes Circulation 115 2007 e356 e375
K. Thygesen, J. Mair, H. Katus Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care Recommendations for the use of cardiac troponin measurement in acute cardiac care Eur Heart J 31 2010 2197 2204
K. Thygesen, J. Mair, E. Giannitsis Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care How to use high-sensitivity cardiac troponins in acute cardiac care Eur Heart J 2012 Jun 21 [Epub ahead of print.]
F.S. Apple, P.O. Collinson IFCC Task Force on Clinical Applications of Cardiac Biomarkers Analytical characteristics of high-sensitivity cardiac troponin assays Clin Chem 58 2012 54 61
A.S. Jaffe, F.S. Apple, D.A. Morrow, B. Lindahl, H.A. Katus Being rational about (im)precision: a statement from the Biochemistry Subcommittee of the Joint European Society of Cardiology/American College of Cardiology Foundation/American Heart Association/World Heart Federation Task Force for the definition of myocardial infarction Clin Chem 56 2010 941 943
A.R. MacRae, P.A. Kavsak, V. Lustig et al. Assessing the requirement for the six-hour interval between specimens in the American Heart Association classification of myocardial infarction in epidemiology and clinical research studies Clin Chem 52 2006 812 818
J.A. de Lemos, M.H. Drazner, T. Omland Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population JAMA 304 2010 2503 2512
T. Omland, J.A. de Lemos, M.S. Sabatine Prevention of Events with Angiotensin Converting Enzyme Inhibition (PEACE) Trial Investigators A sensitive cardiac troponin T assay in stable coronary artery disease N Engl J Med 361 2009 2538 2547
N.L. Mills, A.M. Churchhouse, K.K. Lee Implementation of a sensitive troponin I assay and risk of recurrent myocardial infarction and death in patients with suspected acute conorary syndrome JAMA 305 2011 1210 1216
J.T. Saunders, V. Nambi, J.A. de Limos et al. Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the atherosclerosis risk in communities study Circulation 123 2011 1367 1376
P.A. Kavsak, L. Xu, S. Yusuf, M.J. McQueen High-sensitivity cardiac troponin I measurement for risk stratification in a stable high-risk population Clin Chem 57 2011 1146 1153
F.S. Apple, P.A. Simpson, M.M. Murakami Defining the serum 99th percentile in a normal reference population measured by a high-sensitivity cardiac troponin I assay Clin Biochem 43 2010 1034 1036
E. Giannitsis, K. Kurz, K. Hallermayer, J. Jarausch, A.S. Jaffe, H.A. Katus Analytical validation of a high-sensitivity cardiac troponin T Assay Clin Chem 56 2010 254 261
F.S. Apple, H.E. Quist, P.J. Doyle, A.P. Otto, M.M. Murakami Plasma 99th percentile reference limits for cardiac troponin and creatine kinase MB mass for use with European Society of Cardiology/American College of Cardiology consensus recommendations Clin Chem 49 2003 1331 1336
M.T. Roe, R.A. Harrington, D.M. Prosper et al. Clinical and therapeutic profile of patients presenting with acute coronary syndromes who do not have significant coronary artery disease The Platelet glycoprotein IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) trial Investigators Circulation 102 2000 1101 1106
R. Bugiardini, O. Manfrini, G.M. De Ferrari Unanswered questions for management of acute coronary syndrome: risk stratification of patients with minimal disease or normal findings on coronary angiography Arch Intern Med 166 2006 1391 1395
H.R. Reynolds, M.B. Srichai, S.N. Iqbal Mechanisms of myocardial infarction in women without angiographically obstructive coronary artery disease Circulation 124 2011 1414 1425
M.E. Bertrand, J.M. LaBlanche, P.Y. Tilmant et al. Frequency of provoked coronary arterial spasm in 1089 consecutive patients undergoing coronary arteriography Circulation 65 1982 1299 1306
J.A. Suwaidi, S. Hamasaki, S.T. Higano, R.A. Nishimura, D.R. Holmes Jr., A. Lerman Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction Circulation 101 2000 948 954
R. Bugiardini, O. Manfrini, C. Pizzi, F. Fontana, G. Morgagni Endothelial function predicts future development of coronary artery disease: a study on women with chest pain and normal angiograms Circulation 109 2004 2518 2523
B.M. Harris, T. Nageh, J.T. Marsden, M.R. Thomas, R.A. Sherwood Comparison of cardiac troponin T and I and CK-MB for the detection of minor myocardial damage during interventional cardiac procedures Ann Clin Biochem 37 2000 764 769
J.L. Januzzi, K. Lewandrowski, T.E. MacGillivray A comparison of cardiac troponin T and creatine kinase-MB for patient evaluation after cardiac surgery J Am Coll Cardiol 39 2002 1518 1523
L. Holmvang, B. Jurlander, C. Rasmussen, J.J. Thiis, P. Grande, P. Clemmensen Use of biochemical markers of infarction for diagnosing perioperative myocardial infarction and early graft occlusion after coronary artery bypass surgery Chest 121 2002 103 111
W.L. Miller, K.N. Garratt, M.F. Burritt, G.S. Reeder, A.S. Jaffe Timing of peak troponin T and creatine kinase-MB elevations after percutaneous coronary intervention Chest 25 2004 275 280
A.J. Lansky, G.W. Stone Periprocedural myocardial infarction: prevalence, prognosis, and prevention Circ Cardiovasc Inters 3 2010 602 610
C. Cavallini, P. Verdecchia, S. Savonitto Italian Atherosclerosis, Thrombosis and Vascular Biology and Society for Invasive Cardiology-GISE Investigators Prognostic value of isolated troponin I elevation after percutaneous coronary intervention Circ Cardiovasc Interv 3 2010 431 435
A. Prasad Jr., C.S. Rihal, R.J. Lennon, M. Singh, A.S. Jaffe, D.R. Holmes Jr Significance of periprocedural myonecrosis on outcomes following percutaneous coronary intervention Circ Cardiovasc Intervent 1 2008 10 19
P.J. Zimetbaum, M.E. Josephson Use of the electrocardiogram in acute myocardial infarction N Engl J Med 348 2003 933 940
K. Wang, R.W. Asinger, H.J. Marriott ST-segment elevation in conditions other than acute myocardial infarction N Engl J Med 349 2003 2128 2135
P.W. Mcfarlane Age, sex, and the ST amplitude in health and disease J Electrocardiol 34 2001 S35 S41
P.J. Zimetbaum, S. Krishnan, A. Gold, J.P. Carrozza II, M.E. Josephson Usefulness of ST-segment elevation in lead III exceeding that of lead II for identifying the location of the totally occluded coronary artery in inferior wall myocardial infarction Am J Cardiol 81 1998 918 919
D.J. Engelen, A.P. Gorgels, E.C. Cheriex Value of the electrocardiogram in localizing the occlusion site in the left anterior descending coronary artery in acute anterior myocardial infarction J Am Coll Cardiol 34 1999 389 395
S. Matetzky, D. Freimark, M.S. Feinberg Acute myocardial infarction with isolated ST-segment elevation in posterior chest leads V7-V9 Hidden ST-segment elevations revealing acute posterior infarction J Am Coll Cardiol 34 1999 748 753
J. Lopez-Sendon, I. Coma-Canella, S. Alcasena, J. Seoane, C. Gamallo Electrocardiographic findings in acute right ventricular infarction: sensitivity and specificity of electrocardiographic alterations in right precordial leads V4R, V3R, V1, V2 and V3 J Am Coll Cardiol 6 1985 1273 1279
A. Bayes de Luna, G. Wagner, Y. Birnbaum A new terminology for the left ventricular walls and for the location of myocardial infarcts that present Q wave based on the standard of cardiac magnetic resonance imaging A statement for healthcare professionals from a Committee appointed by the International Society for Holter and Noninvasive Electrocardiography Circulation 114 2006 1755 1760
E.B. Sgarbossa, S.L. Pinsky, A. Barbagelata Electrocardiographic diagnosis of evolving acute myocardial infarction in the presence of left bundle branch block N Engl J Med 334 1996 481 487
S. Jain, H.T. Ting, M. Bell Utility of left bundle branch block as a diagnostic criterion for acute myocardial infarction Am J Cardiol 107 2011 1111 1116
R.M. Savage, G.S. Wagner, R.E. Ideker, S.A. Podolsky, D.B. Hackel Correlation of postmortem anatomic findings with electrocardiographic changes in patients with myocardial infarction: retrospective study of patients with typical anterior and posterior infarcts Circulation 55 1977 279 285
L.G. Horan, N.C. Flowers, J.C. Johnson Significance of the diagnostic Q wave of myocardial infarction Circulation 43 1971 428 436
B.R. Chaitman, R.M. Hardison, D. Adler Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Study Group The Bypass Angioplasty Revascularization Investigation 2 Diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: Impact of treatment strategy on cardiac mortality and myocardial infarction Circulation 120 2009 2529 2540
D.C. Burgess, D. Hunt, D. Zannino et al. Incidence and predictors of silent myocardial infarction in type 2 diabetes and the effect of fenofibrate: an analysis from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study Eur Heart J 31 2010 92 99
S.E. Sheifer, T.A. Manolio, B.J. Gersh Unrecognized myocardial infarction Ann Intern Med 135 2001 801 811
M. Toma, Y. Fu, J.A. Ezekowitz Does silent myocardial infarction add prognostic value in ST-elevation myocardial infarction? Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial Am Heart J 160 2010 671 677
A.E. Stillman, M. Oudkerk, D. Bluemke North American Society of Cardiovascular Imaging; European Society of Cardiac Radiology Assessment of acute myocardial infarction: current status and recommendations from the North American society for Cardiovascular Imaging and the European Society of Cardiac Radiology Int J Cardiovasc Imaging 27 2011 7 24
F.A. Flachskampf, M. Schmid, C. Rost, S. Achenbach, A.N. deMaria, W.G. Daniel Cardiac imaging after myocardial infarction Eur Heart J 32 2011 272 283
S. Kaul, J.G. Miller, P.A. Grayburn et al. A suggested roadmap for cardiovascular ultrasound research for the future J Am Soc Echocardiogr 24 2011 455 464
I. Carrio, M.R. Cowie, J. Yamazaki, J. Udelson, P.G. Camici Cardiac sympathetic imaging with mIBG in heart failure J Am Coll Cardiol Imaging 3 2010 92 100
M. Nahrendorf, D.E. Sosnovik, B.A. French Multimodality cardiovascular molecular imaging, Part II Circ Cardiovasc Imaging 2 2009 56 70
C.M. Kramer, A.J. Sinusas, D.E. Sosnovik, B.A. French, F.M. Bengel Multimodality imaging of myocardial injury and remodeling J Nucl Med 51 2010 107S 121S
H. Taegtmeyer Tracing cardiac metabolism in vivo: one substrate at a time J Nucl Med 51 2010 80S 87S
H.W. Kim, A. Faraneh-Far, R.J. Kim Cardiovascular magnetic resonance in patients with myocardial infarction J Am Coll Cardiol 55 2010 1 16
A.M. Beek, A.C. van Rossum Cardiovascular magnetic resonance imaging in patients with acute myocardial infarction Heart 96 2010 237 243
R.G. Assomull, J.C. Lyne, N. Keenan The role of cardiovascular magnetic resonance in patients presenting with chest pain, raised troponin, and unobstructed coronary arteries Eur Heart J 28 2007 1242 1249
K.H. Schuleri, R.T. George, A.C. Lardo Assessment of coronary blood flow with computed tomography and magnetic resonance imaging J Nucl Cardiol 17 2010 582 590
E.A. Amsterdam, J.D. Kirk, D.A. Bluemke Testing of low-risk patients presenting to the emergency department with chest pain Circulation 122 2010 1756 1776
R.J. Gibbons, U.S. Valeti, P.A. Araoz, A.S. Jaffe The quantification of infarct size J Am Coll Cardiol 44 2004 1533 1542
J. Herrman Peri-procedural myocardial injury: 2005 update Eur Heart J 26 2005 2493 2519
J.B. Selvanayagam, I. Porto, K. Channon Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury: insights from cardiovascular magnetic resonance imaging Circulation 111 2005 1027 1032
C.G. Gustavsson, O. Hansen, B. Frennby Troponin must be measured before and after PCI to diagnose procedure-related myocardial injury Scand Cardiovasc J 38 2004 75 79
W.L. Miller, K.N. Garratt, M.F. Burrit, R.J. Lennon, G.S. Reeder, A.S. Jaffe Baseline troponin level: key to understanding the importance of post-PCI troponin elevations Eur Heart J 27 2006 1061 1069
R.M. Califf, A.E. Abdelmeguid, R.E. Kuntz Myonecrosis after revascularization procedures J Am Coll Cardiol 31 1998 241 251
H.D. White The prequel Defining prognostically important criteria in the periprocedural PCI troponin saga Circ Cardiovasc Interv 5 2012 142 145
A.S. Jaffe, F.S. Apple, B. Lindahl, C. Mueller, H.A. Katus Why all the struggle about CK-MB and PCI? Eur Heart J 33 2012 1046 1048
P. Damman, L. Wallentin, K.A. Fox Long-term cardiovascular mortality after procedure-related or spontaneous myocardial infarction in patients with non-ST-segment elevation acute coronary syndrome: A collaborative analysis of individual patient data from the FRISC II, ICTUS, and RITA-3 Trials (FIR) Circulation 125 2012 568 576
M.P. Bonaca, S.D. Wiviott et al. American College of Cardiology/American Heart Association/European Society of Cardiology/World Heart Federation Universal Definition of Myocardial Infarction Classification System and the risk of cardiovascular death: observations from the TRITON-TIMI 38 Trial (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis in Myocardial Infarction 38) Circulation 125 2012 577 583
D.E. Cutlip, S. Windecker, R. Mehran Academic Research Consortium Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
M.O. Benoit, M. Paris, J. Silleran, A. Fiemeyer, N. Moatti Cardiac troponin I: Its contribution to the diagnosis of perioperative myocardial infarction and various complications of cardiac surgery Crit Care Med 29 2001 1880 1886
R. Kovacevic, N. Majkic-Singh, S. Ignjatovic et al. Troponin T levels in detection of perioperative myocardial infarction after coronary artery bypass surgery Clin Lab 50 2004 437 445
J. Noora, C. Ricci, D. Hastings, S. Hills, I. Cybulsky Determination of Troponin I release after CABG surgery J Card Surg 20 2005 129 135
J.B. Selvanayagam, D. Pigott, L. Balacumaraswami, S.E. Petersen, S. Neubauer, D.P. Taggart Relationship of irreversible myocardial injury to troponin I and creatine kinase-MB elevation after coronary artery bypass surgery: insights from cardiovascular magnetic resonance imaging J Am Coll Cardiol 45 2005 629 631
M.A. Costa, R.G. Carere, S.V. Lichtenstein et al. Incidence, predictors, and significance of abnormal cardiac enzyme rise in patients treated with bypass surgery in the arterial revascularization therapies study (ARTS) Circulation 104 2001 2689 2693
K. Klatte, B.R. Chaitman, P. Theroux et al. Increased mortality after coronary artery bypass graft surgery is associated with increased levels of postoperative creatine kinase-myocardial band isoenzyme release J Am Coll Cardiol 38 2001 1070 1077
S.J. Brener, B.W. Lytle, J.P. Schneider, S.G. Ellis, E.J. Topol Association between CK-MB elevation after percutaneous or surgical revascularization and three-year mortality J Am Coll Cardiol 40 2002 1961 1967
M. Domanski, K. Mahaffey, V. Hasselblad et al. Association of myocardial enzyme elevation and survival following coronary artery bypass graft surgery JAMA 305 2011 585 589
B.L. Croal, G.S. Hillis, P.H. Gibson et al. Relationship between postoperative cardiac troponin I levels and outcome of cardiac surgery Circulation 114 2006 1468 1475
J.B. Selvanayagam, S.E. Petersen, J.M. Francis, M.D. Robson, A. Kardos, S. Neubauer, D.P. Taggart Effects of off-pump versus on-pump coronary surgery on reversible and irreversible myocardial injury: a randomized trial using cardiovascular magnetic resonance imaging and biochemical markers Circulation 109 2004 345 350
M.B. Leon, N. Piazza, E. Nikolsky et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium Eur Heart J 32 2011 205 217 J Am Coll Cardiol 2011;57:253-69
P.J. Devereaux, D. Xavier, J. Pogue POISE (PeriOperative ISchemic Evaluation) Investigators. Characteristics and short-term prognosis of perioperative myocardial infarction in patients undergoing noncardiac surgery: a cohort study Ann Intern Med 154 2011 523 528
The Vascular Events in Noncardiac Surgery Patients Cohort Evaluation (VISION) Study Investigators Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery JAMA 307 2012 2295 2304
P.A. Kavsak, M. Walsh, S. Srinathan et al. High sensitivity troponin T concentrations in patients undergoing noncardiac surgery: a prospective cohort study Clin Biochem 44 2011 1021 1024
L.A. Fleisher, A.H. Nelson, S.H. Rosenbaum Postoperative myocardial ischemia: etiology of cardiac morbidity or manifestation of underlying disease? J Clin Anesth 7 1995 97 102
G. Landesberg, M. Mosseri, V. Shatz et al. Cardiac troponin after major vascular surgery: the role of perioperative ischemia, preoperative thallium scanning, and coronary revascularization J Am Coll Cardiol 44 2004 569 575
M.C. Cohen, T.H. Aretz Histological analysis of coronary artery lesions in fatal postoperative myocardial infarction Cardiovasc Pathol 8 1999 133 139
T.M. Guest, A.V. Ramanathan, P.G. Tuteur, K.B. Schechtman, J.H. Ladenson, A.S. Jaffe Myocardial injury in critically ill medical patients: A surprisingly frequent complication JAMA 273 1995 1945 1949
L. Babuin, V.C. Vasile, J.A. Rio Perez et al. Elevated cardiac troponin is an independent risk factor for short- and long-term mortality in medical intensive care unit patients Crit Care Med 36 2008 759 765
G. Landesberg, Y. Vesselov, S. Einav, S. Goodman, C.L. Sprung, C. Weissman Myocardial ischemia, cardiac troponin, and long-term survival of high-cardiac risk critically ill intensive care unit patients Crit Care Med 33 2005 1281 1287
K. Thygesen, J.S. Alpert, A.S. Jaffe, H.D. White Diagnostic application of the universal definition of myocardial infarction in the intensive care unit Curr Opin Crit Care 14 2008 543 548
R.D. Kociol, P.S. Pang, M. Gheorghiade, G.C. Fonarow, C.M. O'Connor, G.M. Felker Troponin elevation in heart failure prevalence, mechanisms, and clinical implications J Am Coll Cardiol 56 2010 1071 1078
J.L. Januzzi Jr, G. Filippatos, M. Nieminen, M. Gheorghiade Third Universal Task Force for the Definition of Myocardial Infarction: Heart Failure Section Troponin elevation in patients with heart failure Eur Heart J 2012 [Epub ahead of print]
W.L. Miller, K.A. Hartman, M.F. Burritt, D.E. Grill, A.S. Jaffe Profiles of serial changes in cardiac troponin T concentrations and outcome in ambulatory patients with chronic heart failure J Am Coll Cardiol 54 2009 1715 1721
G.D. Dangas, B.E. Claessen, A. Caixeta, E.A. Sanidas, G.S. Mintz, R. Mehran In-stent restenosis in the drug-eluting era J Am Coll Cardiol 56 2010 1897 1907
H.D. White, H.R. Reynolds, A.C. Carvalho et al. Reinfarction after percutaneous coronary intervention or medical management using the universal definition in patients with total occlusion after myocardial infarction: Results from long-term follow-up of the Occluded Artery Trial (OAT) cohort Am Heart J 163 2012 563 571
W. Rosamond, L. Chambless, G. Heiss Twenty-two year trends in incidence of myocardial infarction, CHD mortality, and case-fatality in four US communities, 1987 to 2008 Circulation 125 2012 1848 1857
R. Luepker, S. Duval, D. Jacobs, L. Smith, A. Berger The effect of changing diagnostic algorithms on acute myocardial infarction rates Ann Epidemiology 21 2011 824 829